Reducing the risk of biocontamination in gene, cell and CAR-T therapy

被引：0
|
作者：
Hansen, Rolf [1 ]
机构：
[1] Bioquell
来源：
Manufacturing Chemist | 2020年 / 91卷 / 10期
关键词：
Cytology - Disease control - Diseases - Gene therapy - T-cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
(Edited Abstract)
引用
收藏
页码：30 / 31
相关论文
共 50 条
  • [1] Gene Targets of CAR-T Cell Therapy for Glioblastoma
    Wang, Chaoqun
    Li, Yuntao
    Gu, Lijuan
    Chen, Ran
    Zhu, Hua
    Zhang, Xu
    Zhang, Yonggang
    Feng, Shi
    Qiu, Sheng
    Jian, Zhihong
    Xiong, Xiaoxing
    CANCERS, 2023, 15 (08)
  • [2] CAR-T Cell Therapy
    Ahmad, Aamir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12)
  • [3] CAR-T cell therapy
    San Segundo, Lucrecia Yanez
    MEDICINA CLINICA, 2021, 156 (03): : 123 - 125
  • [4] Risk analysis of leachables in cell and gene therapy using a CAR-T model process
    Budde, Dana
    Jurkiewicz, Elke
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 607
  • [5] CAR-T cell therapy for T cell malignances
    Watanabe, Keisuke
    CANCER SCIENCE, 2025, 116 : 1784 - 1784
  • [6] CAR-T cell therapy for T cell malignances
    Watanabe, Keisuke
    CANCER SCIENCE, 2024, 115 : 812 - 812
  • [7] Biomarkers for CAR-T Cell Therapy
    不详
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 123 - 124
  • [8] CAR-T Cell Therapy and Beyond
    Dotti, Gianpietro
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S4 - S4
  • [9] CAR-T Cell Therapy for Lymphoma
    Ramos, Carlos A.
    Heslop, Helen E.
    Brenner, Malcolm K.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 165 - 183
  • [10] CAR-T Cell Therapy and the Neurointensivist
    Wijdicks, Eelco F. M.
    Rabinstein, Alejandro A.
    Lin, Yi
    NEUROCRITICAL CARE, 2024, : 691 - 694
12345